EGFR, also known as HER1, is also a member of the ErbB family receptor tyrosine kinase, and its overexpression of EGFR can be observed in breast cancer, head-and-neck cancer, non-small cell lung cancer, renal cancer, ovarian cancer, and colon cancer. This evidence concerns the gene EGFR and head and neck cancer.